Device Trial Radar · NCT03321344
Safety and Initial Feasibility of Using the Neurolyser for Facet Related Low Back Pain
Last checked: Nov 19, 2026Latest source record: Jan 25, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
10
Actual
Start
Dec 5, 2017
Primary completion
Feb 28, 2019
Study completion Feb 19, 2020
Sponsor
- Lead sponsor
- FUSMobile Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Focused Ultrasound Foundation
- First posted
- Oct 25, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Single arm pilot study to evaluate the safety and initial feasibility of the Neurolyser XR, a new portable high intensity focused ultrasound device, for noninvasive thermal ablation of medial nerve branches of painful lumbar facet joint/s
Conditions
- Facet Related Low Back Pain
Interventions
Focused Ultrasound Thermal ablationDevice
Focused Ultrasound Thermal ablation of the Medial Nerve Branch
Primary outcomes
What the sponsor says the trial is designed to measure.
- NRSTime frame: Base line, 2 days 1, 2 & 4 weeks, 3, 6 & 12 months after procedure
- RMDTime frame: Base line, 1 & 4 weeks, 3, 6 & 12 months after procedure
- SafteyTime frame: Base line, Procedure day, 2 days 1, 2 & 4 weeks, 3, 6 & 12 months after procedure
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Alan Edwards Pain Management Unit - Montreal General Hospital
Montreal, Quebec, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.